Hela F.
- Country
- France
- Department
- Intensive care
Research Overview
Data & Insights
Has run more than one trial at 0 of 21 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in the treatment of multiple myeloma, with particular focus on developing innovative therapeutic strategies for both newly diagnosed and progressive disease states.
- Novel Treatment Combinations
- Minimal Residual Disease Assessment
- Personalized Therapy Approaches
Their research encompasses treatment protocols involving immunotherapy and targeted therapeutic agents, including innovative applications of daratumumab and lenalidomide.
Transplantation Medicine
The investigator has significant expertise in autologous stem cell transplantation techniques, exploring both single and tandem transplant approaches for hematologic malignancies.
- High-Dose Therapy Protocols
- Transplant Optimization
- Risk-Adapted Strategies
Their work includes developing strategies for transplant-eligible and transplant-ineligible patients, with particular attention to frail patient populations.
Precision Medicine
The investigator focuses on disease monitoring and treatment adaptation based on molecular response, particularly through advanced minimal residual disease detection methods.
- Response-Guided Therapy
- Next-Generation Sequencing
- Treatment Optimization
Their research incorporates sophisticated molecular diagnostic techniques to guide therapeutic decision-making and treatment intensification strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.